GL1X · GenesisL1 explorer

Research workbench

Cetuximab Fab in complex with F3H meditope variant

Analyse Cetuximab Fab in complex with F3H meditope variant in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5EUK
Type
protein
Length
882 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.5
Source
MUS MUSCULUS, HOMO SAPIENS; SYNTHETIC CONSTRUCT
Molecule
Cetuximab Fab light chain; Cetuximab Fab heavy chain; F3H meditope
Ligands
MRY, NAG, PO4
Pockets
12 · best druggability 0.72

Structure

x-ray diffraction · resolution 2.5 · 5 distinct chains · 7% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACetuximab Fab light chainprotein2126% helix, 51% strand—
BCetuximab Fab heavy chainprotein2208% helix, 52% strand—
CCetuximab Fab light chainprotein2136% helix, 50% strand—
DCetuximab Fab heavy chainprotein2137% helix, 52% strand—
E, FF3H meditopeprotein120% helix, 50% strand—

Ligands and binding sites

  • MRY · Meso-erythritol · ligand · chains C
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains B, D
  • PO4 · Phosphate ion · ion · 4 copies · chains A, B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18050.720.7876empty
23740.610.7746empty
33710.600.7748empty
4610.470.8521empty
51110.440.7824empty

Interfaces

7 interfaces between chains.

  • A–B · 1842 Ų buried · 17 hydrogen bonds · protein-protein
  • C–D · 1696 Ų buried · 16 hydrogen bonds · protein-protein
  • A–C · 792 Ų buried · 9 hydrogen bonds · protein-protein
  • C–F · 553 Ų buried · 11 hydrogen bonds · protein-protein
  • A–E · 551 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 10 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 5EUK · Cetuximab Fab in complex with F3H meditope variant · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.